Phenylalanine- and leucine-defined metabolic types identify high mortality risk in patients with severe infection
Author(s) -
Shie-Shian Huang,
Jui-Ying Lin,
Wei-Siang Chen,
Minghui Liu,
ChiWen Cheng,
MeiLing Cheng,
ChaoHung Wang
Publication year - 2019
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2019.05.030
Subject(s) - medicine , intensive care unit , hazard ratio , renal function , incidence (geometry) , risk of mortality , proportional hazards model , leucine , gastroenterology , phenylalanine , confidence interval , biology , biochemistry , physics , amino acid , optics
To investigate the prognostic value of phenylalanine and leucine in patients with severe infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom